Pharmacokinetics of antimicrobial drugs in cystic fibrosis. β-Lactam antibiotics

P. S. Lietman

Research output: Contribution to journalArticle

Abstract

The pharmacodynamics and pharmacokinetics of beta-lactam antibiotics in patients with cystic fibrosis are discussed. A hypothetical dosing regimen based on these principles is considered. The usual dosing regimens may be suboptimal. New dosage regimens should be studied using prospective, controlled, randomized and blinded clinical trials.

Original languageEnglish (US)
Pages (from-to)115S-119S
JournalCHEST
Volume94
Issue number2 SUPPL.
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pharmacokinetics of antimicrobial drugs in cystic fibrosis. β-Lactam antibiotics'. Together they form a unique fingerprint.

  • Cite this